Published in J Neurosci on April 22, 2009
A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell (2010) 7.51
Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature (2010) 5.11
Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature (2012) 3.83
A role for glia in the progression of Rett's syndrome. Nature (2011) 3.18
Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron (2011) 2.71
Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol (2012) 2.42
Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proc Natl Acad Sci U S A (2011) 1.63
Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J Cereb Blood Flow Metab (2009) 1.52
The role of MeCP2 in brain development and neurodevelopmental disorders. Curr Psychiatry Rep (2010) 1.37
Complexities of Rett syndrome and MeCP2. J Neurosci (2011) 1.35
Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp Biol Med (Maywood) (2011) 1.27
Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury. PLoS One (2011) 1.26
MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J Neurosci (2012) 1.25
MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neurons. Exp Neurol (2009) 1.23
Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations. Mol Psychiatry (2012) 1.14
Loss of MeCP2 from forebrain excitatory neurons leads to cortical hyperexcitation and seizures. J Neurosci (2014) 1.11
Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. Hum Mol Genet (2014) 1.10
Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism. J Neurodev Disord (2009) 1.10
The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis. Hum Mol Genet (2010) 1.10
Nonneuronal cells regulate synapse formation in the vestibular sensory epithelium via erbB-dependent BDNF expression. Proc Natl Acad Sci U S A (2010) 1.09
Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome. Neuropsychopharmacology (2011) 1.09
Astroglial cells regulate the developmental timeline of human neurons differentiated from induced pluripotent stem cells. Stem Cell Res (2013) 1.08
Enhanced asynchronous Ca(2+) oscillations associated with impaired glutamate transport in cortical astrocytes expressing Fmr1 gene premutation expansion. J Biol Chem (2013) 1.04
Fragile X astrocytes induce developmental delays in dendrite maturation and synaptic protein expression. BMC Neurosci (2010) 1.04
MeCP2 modulates gene expression pathways in astrocytes. Mol Autism (2013) 1.03
Microglia: key elements in neural development, plasticity, and pathology. J Neuroimmune Pharmacol (2013) 1.02
Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research. Neural Plast (2012) 1.02
The expression of spinal methyl-CpG-binding protein 2, DNA methyltransferases and histone deacetylases is modulated in persistent pain states. Mol Pain (2012) 1.00
The role of microglia in brain maintenance: implications for Rett syndrome. Trends Immunol (2012) 0.99
Epigenetic approaches to psychiatric disorders. Dialogues Clin Neurosci (2010) 0.99
A role for thrombospondin-1 deficits in astrocyte-mediated spine and synaptic pathology in Down's syndrome. PLoS One (2010) 0.98
Converging Pathways in Autism Spectrum Disorders: Interplay between Synaptic Dysfunction and Immune Responses. Front Hum Neurosci (2013) 0.97
Rett syndrome and other autism spectrum disorders--brain diseases of immune malfunction? Mol Psychiatry (2010) 0.97
X-chromosome inactivation in rett syndrome human induced pluripotent stem cells. Front Psychiatry (2012) 0.97
Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome. PLoS One (2012) 0.96
Epigenetic regulation of axon outgrowth and regeneration in CNS injury: the first steps forward. Neurotherapeutics (2013) 0.94
Genetic control of postnatal human brain growth. Curr Opin Neurol (2016) 0.91
Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil. Genes Nutr (2012) 0.91
Concerted control of gliogenesis by InR/TOR and FGF signalling in the Drosophila post-embryonic brain. Development (2012) 0.91
Functional impacts of NRXN1 knockdown on neurodevelopment in stem cell models. PLoS One (2013) 0.90
Astrocytes conspire with neurons during progression of neurological disease. Curr Opin Neurobiol (2012) 0.90
Recent molecular approaches to understanding astrocyte function in vivo. Front Cell Neurosci (2013) 0.88
Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum. Mol Autism (2014) 0.88
Developmental maturation of astrocytes and pathogenesis of neurodevelopmental disorders. J Neurodev Disord (2013) 0.87
Impaired CO2 sensitivity of astrocytes in a mouse model of Rett syndrome. J Physiol (2015) 0.87
Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenes. Eur J Hum Genet (2011) 0.87
Brain region-specific expression of MeCP2 isoforms correlates with DNA methylation within Mecp2 regulatory elements. PLoS One (2014) 0.87
MeCP2 as a genome-wide modulator: the renewal of an old story. Front Genet (2012) 0.87
Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury. Neurotherapeutics (2011) 0.86
Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2). Hum Mol Genet (2013) 0.86
Child and adolescent psychiatric genetics. Eur Child Adolesc Psychiatry (2010) 0.86
DNA methylation reader MECP2: cell type- and differentiation stage-specific protein distribution. Epigenetics Chromatin (2014) 0.86
In sickness and in health: the role of methyl-CpG binding protein 2 in the central nervous system. Eur J Neurosci (2011) 0.86
Identifying essential cell types and circuits in autism spectrum disorders. Int Rev Neurobiol (2013) 0.85
The role of microglia in human disease: therapeutic tool or target? Acta Neuropathol (2014) 0.85
Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes. PLoS One (2012) 0.85
Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity. J Neurosci (2015) 0.85
Does microglial dysfunction play a role in autism and Rett syndrome? Neuron Glia Biol (2012) 0.84
Naltrexone treatment reverses astrocyte atrophy and immune dysfunction in self-harming macaques. Brain Behav Immun (2015) 0.84
The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment. Neurotherapeutics (2015) 0.84
Long-term culture of astrocytes attenuates the readily releasable pool of synaptic vesicles. PLoS One (2012) 0.84
Connexin Type and Fluorescent Protein Fusion Tag Determine Structural Stability of Gap Junction Plaques. J Biol Chem (2015) 0.84
Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage. Mol Brain (2015) 0.83
Central nervous system myeloid cells as drug targets: current status and translational challenges. Nat Rev Drug Discov (2015) 0.83
Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients. Epigenetics (2013) 0.83
MeCP2 dependent heterochromatin reorganization during neural differentiation of a novel Mecp2-deficient embryonic stem cell reporter line. PLoS One (2012) 0.82
Rescue of Methyl-CpG Binding Protein 2 Dysfunction-induced Defects in Newborn Neurons by Pentobarbital. Neurotherapeutics (2015) 0.82
Beyond Widespread Mecp2 Deletions to Model Rett Syndrome: Conditional Spatio-Temporal Knockout, Single-Point Mutations and Transgenic Rescue Mice. Autism Open Access (2012) 0.81
Genotype-specific effects of Mecp2 loss-of-function on morphology of Layer V pyramidal neurons in heterozygous female Rett syndrome model mice. Front Cell Neurosci (2015) 0.81
Concise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient-Derived Induced Pluripotent Stem Cells. Stem Cells (2015) 0.80
Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives. Curr Clin Pharmacol (2013) 0.80
Ocular MECP2 protein expression in patients with and without Rett syndrome. Pediatr Neurol (2010) 0.79
Potential primary roles of glial cells in the mechanisms of psychiatric disorders. Front Cell Neurosci (2015) 0.79
Upregulation of insulin-like growth factor binding protein 3 in astrocytes of transgenic mice that express Borna disease virus phosphoprotein. J Virol (2011) 0.79
Altered microtubule dynamics and vesicular transport in mouse and human MeCP2-deficient astrocytes. Hum Mol Genet (2015) 0.78
Clonal Rett Syndrome cell lines to test compounds for activation of wild-type MeCP2 expression. Bioorg Med Chem Lett (2011) 0.78
Normal mitral cell dendritic development in the setting of Mecp2 mutation. Neuroscience (2011) 0.78
Twenty-four hour quantitative-EEG and in-vivo glutamate biosensor detects activity and circadian rhythm dependent biomarkers of pathogenesis in Mecp2 null mice. Front Syst Neurosci (2014) 0.78
Unexpected cellular players in Rett syndrome pathology. Neurobiol Dis (2015) 0.77
MeCP2 is required for activity-dependent refinement of olfactory circuits. Mol Cell Neurosci (2014) 0.77
Missing and Possible Link between Neuroendocrine Factors, Neuropsychiatric Disorders, and Microglia. Front Integr Neurosci (2013) 0.77
Advancements in the Underlying Pathogenesis of Schizophrenia: Implications of DNA Methylation in Glial Cells. Front Cell Neurosci (2015) 0.77
Functional alterations of astrocytes in mental disorders: pharmacological significance as a drug target. Front Cell Neurosci (2015) 0.76
Neurological and psychiatric disorders as a neuroglial failure. (2014) 0.76
Regulation of mRNA splicing by MeCP2 via epigenetic modifications in the brain. Sci Rep (2017) 0.76
Novel Applications of Magnetic Cell Sorting to Analyze Cell-Type Specific Gene and Protein Expression in the Central Nervous System. PLoS One (2016) 0.76
Astrocytes and Microglia and Their Potential Link with Autism Spectrum Disorders. Front Cell Neurosci (2016) 0.76
Astrocyte-specific regulation of hMeCP2 expression in Drosophila. Biol Open (2014) 0.76
Neurobiologically-based treatments in Rett syndrome: opportunities and challenges. Expert Opin Orphan Drugs (2016) 0.76
A review of Rett syndrome (RTT) with induced pluripotent stem cells. Stem Cell Investig (2016) 0.76
Regulatory functions and pathological relevance of the MECP2 3'UTR in the central nervous system. Cell Regen (Lond) (2015) 0.76
Topoisomerase I inhibition leads to length-dependent gene expression changes in human primary astrocytes. Genom Data (2016) 0.75
Yin-yang actions of histone methylation regulatory complexes in the brain. Epigenomics (2016) 0.75
Immature Neurons and Radial Glia, But Not Astrocytes or Microglia, Are Altered in Adult Cntnap2 and Shank3 Mice, Models of Autism. eNeuro (2016) 0.75
MeCP2-Related Diseases and Animal Models. Diseases (2014) 0.75
Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder? Int J Mol Sci (2017) 0.75
MBD3 expression and DNA binding patterns are altered in a rat model of temporal lobe epilepsy. Sci Rep (2016) 0.75
The Indispensable Roles of Microglia and Astrocytes during Brain Development. Front Hum Neurosci (2016) 0.75
Elevating expression of MeCP2 T158M rescues DNA binding and Rett syndrome-like phenotypes. J Clin Invest (2017) 0.75
Effects of Mecp2 loss of function in embryonic cortical neurons: a bioinformatics strategy to sort out non-neuronal cells variability from transcriptome profiling. BMC Bioinformatics (2016) 0.75
A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci (2008) 17.27
MeCP2, a key contributor to neurological disease, activates and represses transcription. Science (2008) 10.11
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet (2001) 9.82
DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science (2003) 8.81
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet (2001) 8.64
Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science (2003) 8.48
The story of Rett syndrome: from clinic to neurobiology. Neuron (2007) 8.08
Reversal of neurological defects in a mouse model of Rett syndrome. Science (2007) 7.09
Astrocytic purinergic signaling coordinates synaptic networks. Science (2005) 6.55
Postnatal neurodevelopmental disorders: meeting at the synapse? Science (2003) 5.71
The mystery and magic of glia: a perspective on their roles in health and disease. Neuron (2008) 5.32
The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron (2006) 4.74
MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron (2007) 4.15
Astrocytes are active players in cerebral innate immunity. Trends Immunol (2007) 4.08
Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci U S A (2007) 4.00
Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci (2007) 3.81
Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication. Exp Cell Res (1987) 3.28
Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet (2002) 3.12
Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet (2004) 2.89
Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc Natl Acad Sci U S A (2004) 2.87
MeCP2 dysfunction in Rett syndrome and related disorders. Curr Opin Genet Dev (2006) 2.71
Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics (2007) 2.30
Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem (2006) 2.27
Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc Natl Acad Sci U S A (2007) 2.27
Glia are essential for sensory organ function in C. elegans. Science (2008) 2.19
Neuropathology of Rett syndrome. J Child Neurol (2005) 1.83
Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab Invest (1991) 1.78
Gap junctions between cultured astrocytes: immunocytochemical, molecular, and electrophysiological analysis. J Neurosci (1991) 1.74
X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome. Am J Hum Genet (2004) 1.69
Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc Natl Acad Sci U S A (1995) 1.67
Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum Mol Genet (2004) 1.56
Bax involvement in p53-mediated neuronal cell death. J Neurosci (1998) 1.48
X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain. Hum Mol Genet (2004) 1.40
Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum Mol Genet (2001) 1.38
Four classes of intercellular channels between glial cells in the CNS. J Neurosci (2004) 1.32
Gap junction-mediated astrocytic networks in the mouse barrel cortex. J Neurosci (2008) 1.21
Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice. Hum Mol Genet (2008) 1.19
MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum Genet (2002) 1.18
Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. J Neurosci (2005) 1.16
Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice. J Neuroinflammation (2006) 1.14
Ocular dominance plasticity in adult cat visual cortex after transplantation of cultured astrocytes. Nature (1989) 1.11
Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis. Hum Mol Genet (2007) 1.06
A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome. Neuroreport (2008) 1.06
Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model. PLoS One (2007) 1.06
Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Acta Neuropathol (2002) 0.97
Design of an improved set of oligonucleotide primers for genotyping MeCP2tm1.1Bird KO mice by PCR. Mol Neurodegener (2007) 0.89
Increased levels of cyclins D1 and D3 after inhibition of gap junctional communication in astrocytes. J Neurochem (2006) 0.86
Endothelins stimulate the expression of neurotrophin-3 in rat brain and rat cultured astrocytes. Neuroscience (2005) 0.84
Differential neurite growth on astrocyte substrates: interspecies facilitation in green fluorescent protein-transfected rat and human neurons. Neuroscience (2000) 0.82
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging (2008) 14.68
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging (2005) 5.84
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2011) 4.25
Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med (2006) 4.10
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging (2009) 3.97
Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage (2006) 3.85
Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke (2004) 3.80
Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med (2002) 3.31
Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet (2004) 2.89
MCI is associated with deficits in everyday functioning. Alzheimer Dis Assoc Disord (2006) 2.71
Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron (2004) 2.52
3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage (2008) 2.40
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2013) 2.32
Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics (2007) 2.30
Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol (2009) 2.26
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage (2009) 2.03
Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci (2010) 1.98
Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI). Brain Imaging Behav (2012) 1.97
The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13. Neurobiol Dis (2008) 1.97
Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol (2010) 1.94
Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med (2005) 1.90
Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol (2006) 1.89
A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging Behav (2012) 1.88
The human placenta methylome. Proc Natl Acad Sci U S A (2013) 1.86
Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg (2007) 1.83
White matter hyperintensity penumbra. Stroke (2011) 1.78
Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost (2005) 1.77
Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. Neuroimage (2012) 1.76
Central obesity and the aging brain. Arch Neurol (2005) 1.74
Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV. J Acquir Immune Defic Syndr (2005) 1.68
Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol (2007) 1.57
Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum Mol Genet (2004) 1.56
MRI predictors of cognitive change in a diverse and carefully characterized elderly population. Neurobiol Aging (2010) 1.56
Heterogeneity of cognitive trajectories in diverse older persons. Psychol Aging (2010) 1.44
Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele. Am J Pathol (2003) 1.44
Congo red and thioflavin-T analogs detect Abeta oligomers. J Neurochem (2007) 1.43
Venous thromboembolism in ovarian cancer. Gynecol Oncol (2007) 1.42
X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain. Hum Mol Genet (2004) 1.40
Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum Mol Genet (2006) 1.37
The role of MeCP2 in brain development and neurodevelopmental disorders. Curr Psychiatry Rep (2010) 1.37
Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity. J Biol Chem (2010) 1.37
Measuring cognitive reserve based on the decomposition of episodic memory variance. Brain (2010) 1.35
Large-scale methylation domains mark a functional subset of neuronally expressed genes. Genome Res (2011) 1.34
Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J Mol Med (Berl) (2002) 1.32
Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients. Magn Reson Med (2007) 1.27
Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo. J Cell Sci (2008) 1.26
Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice. Neuroreport (2002) 1.23
R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation. Proc Natl Acad Sci U S A (2013) 1.23
Imprinting regulates mammalian snoRNA-encoding chromatin decondensation and neuronal nucleolar size. Hum Mol Genet (2009) 1.21
Phosphorylation of distinct sites in MeCP2 modifies cofactor associations and the dynamics of transcriptional regulation. Mol Cell Biol (2012) 1.20
MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res (2008) 1.19
A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes. J Neurochem (2006) 1.18
Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol (2008) 1.18
MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum Genet (2002) 1.18
Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study. Nucl Med Biol (2010) 1.16
Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity. J Neurochem (2004) 1.14
Long-lived epigenetic interactions between perinatal PBDE exposure and Mecp2308 mutation. Hum Mol Genet (2012) 1.12
Young adult female fragile X premutation carriers show age- and genetically-modulated cognitive impairments. Brain Cogn (2011) 1.12
Isoform-specific knockout of FE65 leads to impaired learning and memory. J Neurosci Res (2004) 1.11
Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin. Cancer (2003) 1.11
Levels of select PCB and PBDE congeners in human postmortem brain reveal possible environmental involvement in 15q11-q13 duplication autism spectrum disorder. Environ Mol Mutagen (2012) 1.09
Genetic modulation of tau phosphorylation in the mouse. J Neurosci (2003) 1.09
Role of DNMT3B in the regulation of early neural and neural crest specifiers. Epigenetics (2012) 1.09
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol (2014) 1.08
Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients. BMC Med Genet (2006) 1.08
Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Abeta oligomer-induced cytotoxicity. Brain Res (2006) 1.07
Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism. Hum Mol Genet (2008) 1.06
Adult Female Fragile X Premutation Carriers Exhibit Age- and CGG Repeat Length-Related Impairments on an Attentionally Based Enumeration Task. Front Hum Neurosci (2011) 1.06
Maximal brain size remains an important predictor of cognition in old age, independent of current brain pathology. Neurobiol Aging (2011) 1.06
Dynamic changes in Histone H3 lysine 9 acetylation localization patterns during neuronal maturation require MeCP2. Epigenetics (2007) 1.05
Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease. Arch Neurol (2006) 1.05
The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer. Cancer (2010) 1.05
Inhibition of Alzheimer's amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo. J Neurochem (2009) 1.05
Multiple forms of atypical rearrangements generating supernumerary derivative chromosome 15. BMC Genet (2008) 1.04
Mapping the structural transition in an amyloidogenic apolipoprotein A-I. Biochemistry (2007) 1.03
Demographic predictors of cognitive change in ethnically diverse older persons. Psychol Aging (2013) 1.03
MeCP2 modulates gene expression pathways in astrocytes. Mol Autism (2013) 1.03
New diphenylacetylenes as probes for positron emission tomographic imaging of amyloid plaques. J Med Chem (2007) 1.02
Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma? Cancer (2002) 1.01
Enhanced manual and oral motor reaction time in young adult female fragile X premutation carriers. J Int Neuropsychol Soc (2011) 1.00
Comparison of retinal nerve fiber layer and central macular thickness measurements among five different optical coherence tomography instruments in patients with multiple sclerosis and optic neuritis. J Neuroophthalmol (2011) 0.99
High-grade transgenic somatic chimeras from chicken embryonic stem cells. Mech Dev (2005) 0.98
Early intraneuronal Abeta deposition in the hippocampus of APP transgenic mice. Neuroreport (2003) 0.97
MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturation. Neurobiol Dis (2011) 0.95
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
A differential association of Apolipoprotein E isoforms with the amyloid-β oligomer in solution. Proteins (2011) 0.94
Clinical features, with video documentation, of the original familial lewy body parkinsonism caused by α-synuclein triplication (Iowa kindred). Mov Disord (2011) 0.93
Adaptive image segmentation for robust measurement of longitudinal brain tissue change. Conf Proc IEEE Eng Med Biol Soc (2012) 0.93
Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro. J Neurosci Res (2005) 0.93
Gender influences monoallelic expression of ATP10A in human brain. Hum Genet (2008) 0.93
Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease. J Lipid Res (2003) 0.93
Metabolic syndrome and mammographic density: the Study of Women's Health Across the Nation. Int J Cancer (2011) 0.92
Physical activity and change in mammographic density: the Study of Women's Health Across the Nation. Am J Epidemiol (2010) 0.92
Niemann-Pick disease type C yields possible clue for why cerebellar neurons do not form neurofibrillary tangles. Neurobiol Dis (2002) 0.91
Co-morbidity is a strong predictor of early death and multi-organ system failure among patients with acute pancreatitis. J Gastrointest Surg (2007) 0.90
Candidate anti-A beta fluorene compounds selected from analogs of amyloid imaging agents. Neurobiol Aging (2008) 0.90
A novel hypomorphic MECP2 point mutation is associated with a neuropsychiatric phenotype. Hum Genet (2008) 0.90